|
Status |
Public on Sep 06, 2022 |
Title |
MB49_POM1_2 |
Sample type |
SRA |
|
|
Source name |
bladder cancer
|
Organism |
Mus musculus |
Characteristics |
tissue: MB49 Subcutaneous tumors strain: C57BL/6 genotype: wild type marker: CD45+ sorted treatment: POM-1 treated
|
Treatment protocol |
5 mg/kg of the NTPDase inhibitor sodium polyoxotungstate (POM-1/CD39i, purchased from Santa Cruz Biotechnology, Inc., Dallas, Texas, USA) once per day from day 6 to day 22.
|
Growth protocol |
MB49 Subcutaneous tumors.
|
Extracted molecule |
total RNA |
Extraction protocol |
After single cell suspension, CD45+ cells were sorted. Barcoded scRNA-seq libraries were prepared using the Chromium Single Cell 3’ v3 Reagent Kit.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
HiSeq X Ten |
|
|
Data processing |
Single-cell RNA sequencing data was collected on a Hiseq X Ten Illumina instrument. Alignment using Cell Ranger (5.0.0) from 10x Genomics. Genome_build: mm10 (GRCm38) Supplementary_files_format_and_content: *.tar: Tar archives include barcodes.tsv.gz, features.tsv.gz, and matrix.mtx.gz files.
|
|
|
Submission date |
Nov 18, 2021 |
Last update date |
Sep 06, 2022 |
Contact name |
Junyi Hu |
Organization name |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
|
Department |
Urology
|
Street address |
No. 1277 Liberation Avenue
|
City |
Wu Han |
ZIP/Postal code |
430022 |
Country |
China |
|
|
Platform ID |
GPL21273 |
Series (1) |
GSE189127 |
Single-Cell Sequencing Reveals the Overall Changes in Tumor Microenvironment Mediated by CD39i |
|
Relations |
BioSample |
SAMN23283074 |
SRA |
SRX13166376 |